Multiscale Entropy Algorithms to Analyze Complexity and Variability of Trunk Accelerations Time Series in Subjects with Parkinson's Disease

The aim of this study was to assess the ability of multiscale sample entropy (MSE), refined composite multiscale entropy (RCMSE), and complexity index (CI) to characterize gait complexity through trunk acceleration patterns in subjects with Parkinson's disease (swPD) and healthy subjects, regardless of age or gait speed. The trunk acceleration patterns of 51 swPD and 50 healthy subjects (HS) were acquired using a lumbar-mounted magneto-inertial measurement unit during their walking. MSE, RCMSE, and CI were calculated on 2000 data points, using scale factors (t) 1-6. Differences between swPD and HS were calculated at each t, and the area under the receiver operating characteristics, optimal cutoff points, post-test probabilities, and diagnostic odds ratios were calculated. MSE, RCMSE, and CIs showed to differentiate swPD from HS. MSE in the anteroposterior direction at t4 and t5, and MSE in the ML direction at t4 showed to characterize the gait disorders of swPD with the best trade-off between positive and negative posttest probabilities and correlated with the motor disability, pelvic kinematics, and stance phase. Using a time series of 2000 data points, a scale factor of 4 or 5 in the MSE procedure can yield the best trade-off in terms of post-test probabilities when compared to other scale factors for detecting gait variability and complexity in swPD.

Automated summary

The aim of this study was to assess the ability of MSE, RCMSE, and CI to characterize gait complexity in subjects with Parkinson's disease and healthy subjects. Trunk acceleration patterns were acquired and analyzed, and these measures were found to differentiate Parkinson's disease patients from healthy subjects and were correlated with motor disability and other factors. A scale factor of 4 or 5 in the MSE procedure yielded the best trade-off in terms of post-test probabilities for detecting gait variability and complexity in Parkinson's disease.